Silencing hepatitis B virus prevent recurrence of liver cancer
Thursday, June 24, 2010 - 11:32
in Health & Medicine
Previous studies have shown that antiviral treatment reduces the incidence of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). But now, researchers from the Division of Gastroenterology and Hepatology at Thomas Jefferson University are reporting that the antiviral therapy also prevents recurrence of HCC and extends patients' lives.